EVALUATING THE EFFECT OF TRIPHALA BHAVITA YAVA SAKTU AND TRIPHALA BHAVITA SYAMAK SAKTU ALONG WITH DIET REGIMEN ( PATHYA AHARA) IN THE MANAGEMENT OF TYPE II DIABETES MELLITUS

A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF TRIPHALA BHAVITA YAVA SAKTU AND TRIPHALA BHAVITA SYAMAK SAKTU ALONG WITH DIET REGIMN PATHYA AHARA IN THE MANAGEMENT OF DIABETES MELLITUS - A RANDOMIZED CONTROL OPEN LABEL CLINICAL TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076594

Enrollment

Registered

2024-11-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with age group 35-60 years, suffering from Diabetes Mellitus type II. 2. Newly diagnosed case of DM type 2 with FBS 126mg/dl – 220mg/dl and PPS 180mg/dl – 280mg/dl and HbA1c range between 6.5% - 7.5% 3. Patient willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patient suffering from Type 1 Diabetes Mellitus and other complications of diabetes such as diabetic neuropathy, Diabetic Retinopathy, Ischemic heart disease. 2. Patient with cardiovascular disease and other systemic Illness. 3. Pregnant women and lactating mother. 4. Patients not willing to participate in the Study

Design outcomes

Primary

Measure	Time frame
Significant improvement in Symptoms of MadhumehaTimepoint: 90 days	—

Secondary

Measure	Time frame
Improvement in Hba1c,FBS,PPBSTimepoint: 90 Days	—

Countries

India

Contacts

Public ContactDr Medha Kulkarni

All India Institute of Ayurveda

shivakumarsharti@gmail.com9611275434

Outcome results